Bioventus Inc.
BVSMedical Devices
$13.33−10.39%As of Oct 30vs prior close
- Market cap
- $910.2M
- P/E (TTM)
- 16.5×
- P/E (FY1)
- 17.1×
- From 52W high
- −12.68%
- EPS (LTM)
- $0.77
- Revenue (LTM)
- $581.8M
- Net margin
- 9.36%
- Dividend yield
- 0.00%
Nomior Score
81
Discounted QualityTop 2% of the scored universe
Growth51
Quality80
Value78
Momentum96
Resilience40
Growth
+8.92%revenue a year over 6 fiscal years
YE19 $340.1MLTM $581.8M
Connections
Revenue to profitQ2 YE26
22% of revenue became net profit, up 17 pts on a year.
Who owns it
2funds